Evidence-Based Novel Therapies for Bipolar Depression: Top 5 Takeaways

Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.

Related Videos

Related Content

Advertisement

June 17th 2025

ADHD With Bipolar Disorder: Genetics, Diagnosis, and New Thinking on Treatment

David N. Osser, MD

October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP

May 29th 2025

Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists

Leah Kuntz

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

May 13th 2025

Diagnosis in Bipolar Disorder: Dealing With Comorbidity

David N. Osser, MD

May 12th 2025

The Double-Edged Sword of Affluence

Danielle Egbe, DO Christina B. Smith, MD

Related Content

Advertisement

June 17th 2025

ADHD With Bipolar Disorder: Genetics, Diagnosis, and New Thinking on Treatment

David N. Osser, MD

October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP

May 29th 2025

Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists

Leah Kuntz

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

May 13th 2025

Diagnosis in Bipolar Disorder: Dealing With Comorbidity

David N. Osser, MD

May 12th 2025

The Double-Edged Sword of Affluence

Danielle Egbe, DO Christina B. Smith, MD